Harvard Bioscience Inc (HBIO) FY2025Q2 Earning Prediction
Harvard Bioscience Inc (HBIO) is set to release its earnings performance on 08/11 07:00:00 ET in Pre-Market trading. Consensus forecasts predict a revenue of 18.75M and an earnings per share (EPS) of -0.01 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
Earnings Surprise Analysis
HBIO Transcript
The earnings call reflects a positive sentiment with strong financial performance, including increased EBITDA, net profit, and EPS. Despite some uncertainties in CapEx and costs, the company shows confidence in resolving issues and improving production. The anticipated strong Q4 and optimistic 2026 outlook, alongside potential cost reductions and share buybacks, support a positive stock price movement.
The earnings call presents a mixed picture. Financial performance shows positive elements like high gross margins and improved EBITDA, yet revenue declined YoY. Challenges such as NIH funding delays, China market struggles, and tariff impacts create uncertainties. However, optimistic guidance and product development initiatives provide potential upside. The Q&A reveals cautious optimism but highlights risks like NIH funding delays. Overall, the sentiment is neutral due to balanced positive and negative factors, with no strong catalysts to drive significant stock price movement in the short term.
Despite some positive elements like cost reduction and improved cash flow, the overall sentiment is negative due to the revenue decline, gross margin pressure, debt risks, and macroeconomic uncertainties, including tariffs and NIH funding delays. The Q&A section highlighted concerns about debt refinancing and unclear guidance on NIH budget impacts. Given these factors, along with the lack of a clear positive catalyst, the stock price is likely to experience a negative movement in the next two weeks.
The earnings call reveals several negative indicators: a significant revenue decline, a $48 million goodwill impairment, and decreased margins. Despite cost reduction efforts, challenges in sales due to budget uncertainties and tariffs persist. While there is interest in new products, the impact of NIH funding cuts and unclear refinancing terms add to the uncertainty. The lack of a share repurchase program further dampens sentiment. These factors suggest a negative stock price reaction, potentially in the -2% to -8% range.
HBIO Slides
HBIO Report
Frequently Asked Questions
What is the Harvard Bioscience Inc FY2025Q2 Earnings Release Date and Time?
Harvard Bioscience Inc (HBIO) is scheduled to release its FY2025Q2 earnings report onAug 11, 2025, Pre-Market(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for Harvard Bioscience Inc FY2025Q2 Revenue and EPS?
Analysts' consensus predicts 18.75M in revenue and an EPS of -0.01 for Harvard Bioscience Inc's FY2025Q2.
What Does Intellectia's AI Predict for Harvard Bioscience Inc FY2025Q2 Earnings?
Intellectia's exclusive AI algorithms forecast a forHarvard Bioscience Inc's FY2025Q2 earnings, with a prediction date of Aug 11, 2025. Harvard Bioscience Inc
How Can I Use This Earnings Prediction to Trade HBIO Stock?
Leverage Intellectia's AI forecast to position trades ahead of theAug 11, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like Harvard Bioscience Inc FY2025Q2?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
